| Thursday 26 November - Day one | |
| 10.30am | Registration, welcome refreshments, exhibition and poster viewing |
| 11.00am | Chair's welcome and introduction Dr Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Chair, UK SABR Consortium |
| 11.05am | What is the current role of SABR in breast cancer? Professor Anna Kirby, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust |
| 11.35am | Updates in HPB SABR Dr Tasos Loannou, Consultant Clinical Oncologist, The Clatterbridge Cancer, Dr Arabella Hunt, Consultant Clinical Oncologist and Dr Katharine Aitken, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust |
| 12.05pm | Sponsored session |
| 12.35pm | SABR QA Programme and trials update Patricia Diez, Lead Clinical Scientist, RTTQA, Mount Vernon Cancer Centre and Jo Cook, Research & Development and RTTQA Specialist Dosimetrist · University College London Hospitals NHS Foundation Trust |
| 1.05pm | Lunch, exhibition and poster viewing |
| 2.10pm | Adaptive Radiotherapy: Is it worth the effort? Dr Susan Lalondrelle, Consultant Clinical Oncologist, Alex Dunlop, Radiotherapy Physicist and Shabanaz Boodho, Radiographer, The Royal Marsden NHS Foundation Trust |
| 3.10pm | Proffered papers showcase - a selection of short papers from submitted abstracts |
| 4.00pm | Refreshments, exhibition and poster viewing |
| 4.30pm | Beyond
MU: Geometric assessment of plan modulation and complexity in SABR Dr Jordi Saez Beltran, Medical Physicist, Hospital Clinic de Barcelona, Spain |
| 5.00pm | How to get involved in radiotherapy research Dr Rebecca Muirhead, Consultant Clinical Oncologist, Oxford University Hospitals NHS Foundation Trust and Vice-Chair, UK SABR Consortium |
| 5.30pm | Sequencing SABR with systemic therapy - what do you need to stop? Dr Sean O’Cathail, Consultant Radiation Oncologist at Cork University Hospital, Ireland |
| 6.00pm | Close of Day one |
| 7.30pm | UK SABR Consortium Annual Conference Dinner DoubleTree by Hilton Brighton Metropole |
| Friday 27 November - Day two | |
| 8.30am | Registration, welcome refreshments, exhibition and poster viewing |
| 8.45am | Chair's introduction Dr Rebecca Muirhead |
| 8.50am | Keynote address Dr Arjun Sahgal, Senior Scientist, Radiation Oncologist, Sunnybrook Health Sciences Centre, Toronto, Canada |
| 9.30am | Delivering an ablative radiation dose in a single fraction - what technical considerations are there? Professor Marcel Van Herk, University of Manchester |
| 10.00am | The Great British SABR MDT Panel of expert speakers |
| 11.00am | Refreshments, exhibition and poster viewing |
| 11.30am | Considerations for radiographers in delivering SABR Speakers tbc |
| 12.00pm | Sponsored session |
| 12.30pm | Proffered papers showcase - a selection of short papers from submitted abstracts |
| 1.20pm | Lunch, final exhibition and poster viewing |
| 2.20pm | The role of SABR in lung cancer Dr Fiona McDonald, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust |
| 2.50pm | The Annual SABR debate - SABR is the standard of care for spinal metastases For: Dr Arjun Sahgal and Dr Alison Tree, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust Against: Dr Sean O’Cathail and Professor Peter Hoskin, Reader in Oncology, Mount Vernon Hospital |
| 4.00pm | Closing remarks Dr Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Chair, UK SABR Consortium |